Singapore markets closed

MacroGenics, Inc. (MGNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.56+0.19 (+1.32%)
At close: 04:00PM EDT
14.56 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 910.88M
Enterprise value 715.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)15.77
Price/book (mrq)5.97
Enterprise value/revenue 12.50
Enterprise value/EBITDA 354.51

Trading information

Stock price history

Beta (5Y monthly) 2.11
52-week change 396.49%
S&P500 52-week change 322.36%
52-week high 321.88
52-week low 34.29
50-day moving average 316.73
200-day moving average 39.80

Share statistics

Avg vol (3-month) 31.55M
Avg vol (10-day) 3789.85k
Shares outstanding 562.56M
Implied shares outstanding 662.56M
Float 852.17M
% held by insiders 12.61%
% held by institutions 1100.50%
Shares short (15 Apr 2024) 48.6M
Short ratio (15 Apr 2024) 45.19
Short % of float (15 Apr 2024) 416.88%
Short % of shares outstanding (15 Apr 2024) 413.75%
Shares short (prior month 15 Mar 2024) 45.6M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -15.42%
Operating margin (ttm)-460.39%

Management effectiveness

Return on assets (ttm)-36.33%
Return on equity (ttm)-6.15%

Income statement

Revenue (ttm)58.75M
Revenue per share (ttm)0.95
Quarterly revenue growth (yoy)-85.30%
Gross profit (ttm)N/A
EBITDA -158.6M
Net income avi to common (ttm)-9.06M
Diluted EPS (ttm)-0.15
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)229.8M
Total cash per share (mrq)3.68
Total debt (mrq)33.97M
Total debt/equity (mrq)22.26%
Current ratio (mrq)4.48
Book value per share (mrq)2.46

Cash flow statement

Operating cash flow (ttm)-78.2M
Levered free cash flow (ttm)-25.04M